In the last 12 months, insiders at INSMED Inc ($INSM) filed 770 transactions with the SEC: 2 open-market purchases totaling $201,694 and 382 sales totaling $339,569,774. Net insider sentiment: net selling.
INSMED Inc operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Flammer Martina M.D. (Chief Medical Officer) — 140 transactions totaling $92,333,749
- Lewis William (Chair and CEO) — 244 transactions totaling $75,744,368
- Schaeffer Orlov S Nicole (Chief People Strategy Officer) — 80 transactions totaling $74,012,965
- Bonstein Sara (Chief Financial Officer) — 91 transactions totaling $53,280,233
- Smith Michael Alexander (Chief Legal Officer) — 78 transactions totaling $35,281,488
View all SEC Filings for INSMED Inc (INSM).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 19001 | $164.11 | 169,154.0000 | 215,551,896 | 10.10% | 0.01% |
| April 1, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 6715 | $163.18 | 188,155.0000 | 215,551,896 | 3.45% | 0.00% |
| April 1, 2026 | Adsett Roger | Chief Operating Officer | M | Common Stock | 88060 | $14.56 | 194,870.0000 | 215,551,896 | 82.45% | 0.04% |
| April 1, 2026 | Adsett Roger | Chief Operating Officer | M | Stock Option (right to buy) | 88060 | $0.00 | 0.0000 | 215,551,896 | 100.00% | 0.04% |
| April 1, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 62344 | $164.95 | 106,810.0000 | 215,551,896 | 36.86% | 0.03% |
| March 30, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 19638 | $150.98 | 51,871.0000 | 215,551,896 | 27.46% | 0.01% |
| March 30, 2026 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 13989 | $27.89 | 71,509.0000 | 215,551,896 | 24.32% | 0.01% |
| March 30, 2026 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 5649 | $17.07 | 57,520.0000 | 215,551,896 | 10.89% | 0.00% |
| March 30, 2026 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 13989 | $0.00 | 18,561.0000 | 215,551,896 | 42.98% | 0.01% |
| March 30, 2026 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 5649 | $0.00 | 8,633.0000 | 215,551,896 | 39.55% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 35,520.0000 | 215,551,896 | 11.11% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 541,368.0000 | 215,551,896 | 1.17% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 545,808.0000 | 215,551,896 | 0.82% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1629 | $142.17 | 544,179.0000 | 215,551,896 | 0.30% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 4537 | $143.42 | 539,642.0000 | 215,551,896 | 0.83% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 4533 | $144.11 | 535,109.0000 | 215,551,896 | 0.84% | 0.00% |
| March 19, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 50,073.0000 | 215,551,896 | 11.11% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 56,332.0000 | 215,551,896 | 10.00% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | S | Common Stock | 2128 | $147.54 | 535,109.0000 | 215,551,896 | 0.40% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 39,960.0000 | 215,551,896 | 10.00% | 0.00% |
| March 3, 2026 | SHAROKY MELVIN MD | Director | G | Common Stock | 100 | $0.00 | 269,596.0000 | 215,551,896 | 0.04% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | S | Common Stock | 3899 | $146.66 | 537,237.0000 | 215,551,896 | 0.72% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | S | Common Stock | 2589 | $145.27 | 541,136.0000 | 215,551,896 | 0.48% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | S | Common Stock | 2083 | $144.23 | 543,725.0000 | 215,551,896 | 0.38% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 545,808.0000 | 215,551,896 | 0.82% | 0.00% |
| March 5, 2026 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 541,368.0000 | 215,551,896 | 1.17% | 0.00% |
| Feb. 25, 2026 | SHAROKY MELVIN MD | Director | G | Common Stock | 243 | $0.00 | 269,696.0000 | 215,551,896 | 0.09% | 0.00% |
| Feb. 25, 2026 | SHAROKY MELVIN MD | Director | G | Common Stock | 243 | $0.00 | 269,696.0000 | 215,551,896 | 0.09% | 0.00% |
| Feb. 25, 2026 | SHAROKY MELVIN MD | Director | G | Common Stock | 243 | $0.00 | 269,696.0000 | 215,551,896 | 0.09% | 0.00% |
| Feb. 25, 2026 | SHAROKY MELVIN MD | Director | G | Common Stock | 243 | $0.00 | 269,696.0000 | 215,551,896 | 0.09% | 0.00% |
| Feb. 25, 2026 | SHAROKY MELVIN MD | Director | G | Common Stock | 1072 | $0.00 | 269,696.0000 | 215,551,896 | 0.40% | 0.00% |
| Feb. 24, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 4852 | $153.93 | 71,793.0000 | 215,551,896 | 6.33% | 0.00% |
| Feb. 23, 2026 | Brennan David R | Director | G | Common Stock | 6000 | $0.00 | 120,933.0000 | 215,551,896 | 4.73% | 0.00% |
| Feb. 24, 2026 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 20248 | $0.00 | 14,282.0000 | 215,551,896 | 58.64% | 0.01% |
| Feb. 24, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 15771 | $156.53 | 51,871.0000 | 215,551,896 | 23.32% | 0.01% |
| Feb. 24, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 4151 | $155.06 | 67,642.0000 | 215,551,896 | 5.78% | 0.00% |
| Feb. 24, 2026 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 20248 | $17.07 | 76,645.0000 | 215,551,896 | 35.90% | 0.01% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 591,868.0000 | 215,551,896 | 1.07% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 62,591.0000 | 215,551,896 | 9.09% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1030 | $153.38 | 585,609.0000 | 215,551,896 | 0.18% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 2377 | $151.92 | 586,639.0000 | 215,551,896 | 0.40% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 3413 | $151.12 | 589,016.0000 | 215,551,896 | 0.58% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1891 | $150.10 | 592,429.0000 | 215,551,896 | 0.32% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1988 | $149.17 | 594,320.0000 | 215,551,896 | 0.33% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 596,308.0000 | 215,551,896 | 0.75% | 0.00% |
| Feb. 19, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 44,400.0000 | 215,551,896 | 9.09% | 0.00% |
| Feb. 9, 2026 | MCGIRR DAVID W J | Director | G | Common Stock | 53400 | $0.00 | 97,723.0000 | 213,273,469 | 120.48% | 0.03% |
| Feb. 9, 2026 | MCGIRR DAVID W J | Director | G | Common Stock | 53400 | $0.00 | 97,723.0000 | 213,273,469 | 35.34% | 0.03% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 68,850.0000 | 213,273,469 | 8.33% | 0.00% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 48,840.0000 | 213,273,469 | 8.33% | 0.00% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1287 | $148.83 | 585,609.0000 | 213,273,469 | 0.22% | 0.00% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | S | Common Stock | 7221 | $148.02 | 586,896.0000 | 213,273,469 | 1.22% | 0.00% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | S | Common Stock | 4888 | $147.17 | 594,117.0000 | 213,273,469 | 0.82% | 0.00% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 599,005.0000 | 213,273,469 | 1.06% | 0.00% |
| Feb. 9, 2026 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 592,746.0000 | 213,273,469 | 0.75% | 0.00% |
| Feb. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 869 | $152.44 | 83,243.0000 | 213,273,469 | 1.03% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 7982 | $0.00 | 23,948.0000 | 213,273,469 | 25.00% | 0.00% |
| Feb. 3, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 795 | $155.77 | 84,112.0000 | 213,273,469 | 0.94% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 100 | $156.86 | 84,907.0000 | 213,273,469 | 0.12% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 3042 | $155.46 | 85,007.0000 | 213,273,469 | 3.45% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 3349 | $154.56 | 88,049.0000 | 213,273,469 | 3.66% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 928 | $153.16 | 91,398.0000 | 213,273,469 | 1.01% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 563 | $152.06 | 92,326.0000 | 213,273,469 | 0.61% | 0.00% |
| Feb. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 7982 | $65.72 | 92,889.0000 | 213,273,469 | 9.40% | 0.00% |
| Feb. 3, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 640 | $156.27 | 56,397.0000 | 213,273,469 | 1.12% | 0.00% |
| Feb. 3, 2026 | Lewis William | Chair and CEO | S | Common Stock | 3009 | $156.34 | 588,306.0000 | 213,273,469 | 0.51% | 0.00% |
| Feb. 3, 2026 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 748 | $156.34 | 79,758.0000 | 213,273,469 | 0.93% | 0.00% |
| Feb. 3, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 791 | $156.17 | 106,810.0000 | 213,273,469 | 0.74% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 53,280.0000 | 213,273,469 | 7.69% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 75,109.0000 | 213,273,469 | 7.69% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | S | Common Stock | 254 | $160.70 | 591,315.0000 | 213,273,469 | 0.04% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | S | Common Stock | 2229 | $159.85 | 591,569.0000 | 213,273,469 | 0.38% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | S | Common Stock | 5967 | $158.99 | 593,798.0000 | 213,273,469 | 0.99% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1243 | $158.37 | 599,765.0000 | 213,273,469 | 0.21% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | S | Common Stock | 1006 | $156.80 | 601,008.0000 | 213,273,469 | 0.17% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 602,014.0000 | 213,273,469 | 0.74% | 0.00% |
| Jan. 20, 2026 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 597,574.0000 | 213,273,469 | 1.06% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 57,720.0000 | 213,273,469 | 7.14% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 81,368.0000 | 213,273,469 | 7.14% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 315 | $174.86 | 591,315.0000 | 213,273,469 | 0.05% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 297 | $172.36 | 591,630.0000 | 213,273,469 | 0.05% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 297 | $171.31 | 591,927.0000 | 213,273,469 | 0.05% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 160 | $170.24 | 592,224.0000 | 213,273,469 | 0.03% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 6996 | $169.57 | 592,384.0000 | 213,273,469 | 1.17% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 7176 | $168.63 | 599,380.0000 | 213,273,469 | 1.18% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | S | Common Stock | 3974 | $167.73 | 606,556.0000 | 213,273,469 | 0.65% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 610,530.0000 | 213,273,469 | 0.73% | 0.00% |
| Jan. 12, 2026 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 606,090.0000 | 213,273,469 | 1.04% | 0.00% |
| Jan. 9, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1887 | $186.19 | 84,907.0000 | 213,273,469 | 2.17% | 0.00% |
| Jan. 6, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1615 | $173.33 | 93,139.0000 | 213,273,469 | 1.70% | 0.00% |
| Jan. 6, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 1429 | $173.33 | 110,462.0000 | 213,273,469 | 1.28% | 0.00% |
| Jan. 7, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 802 | $175.07 | 109,660.0000 | 213,273,469 | 0.73% | 0.00% |
| Jan. 8, 2026 | Adsett Roger | Chief Operating Officer | S | Common Stock | 2059 | $174.17 | 107,601.0000 | 213,273,469 | 1.88% | 0.00% |
| Jan. 6, 2026 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1517 | $173.33 | 83,631.0000 | 213,273,469 | 1.78% | 0.00% |
| Jan. 7, 2026 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1678 | $175.07 | 81,953.0000 | 213,273,469 | 2.01% | 0.00% |
| Jan. 8, 2026 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1447 | $174.17 | 80,506.0000 | 213,273,469 | 1.77% | 0.00% |
| Jan. 6, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 8570 | $26.43 | 103,324.0000 | 213,273,469 | 9.04% | 0.00% |
| Jan. 6, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 4783 | $173.47 | 98,541.0000 | 213,273,469 | 4.63% | 0.00% |
| Jan. 6, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 2830 | $174.21 | 95,711.0000 | 213,273,469 | 2.87% | 0.00% |
| Jan. 6, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 957 | $175.01 | 94,754.0000 | 213,273,469 | 1.00% | 0.00% |
| Jan. 7, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1434 | $175.84 | 91,705.0000 | 213,273,469 | 1.54% | 0.00% |
| Jan. 8, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1660 | $173.87 | 90,045.0000 | 213,273,469 | 1.81% | 0.00% |
| Jan. 8, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 3251 | $174.17 | 86,794.0000 | 213,273,469 | 3.61% | 0.00% |
| Jan. 6, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 8570 | $0.00 | 0.0000 | 213,273,469 | 100.00% | 0.00% |
| Jan. 6, 2026 | Lewis William | Chair and CEO | S | Common Stock | 4096 | $173.33 | 605,411.0000 | 213,273,469 | 0.67% | 0.00% |
| Jan. 7, 2026 | Lewis William | Chair and CEO | S | Common Stock | 2357 | $175.07 | 603,054.0000 | 213,273,469 | 0.39% | 0.00% |
| Jan. 8, 2026 | Lewis William | Chair and CEO | S | Common Stock | 3223 | $174.17 | 599,831.0000 | 213,273,469 | 0.53% | 0.00% |
| Jan. 6, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1396 | $173.33 | 58,799.0000 | 213,273,469 | 2.32% | 0.00% |
| Jan. 7, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 709 | $175.07 | 58,090.0000 | 213,273,469 | 1.21% | 0.00% |
| Jan. 8, 2026 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1053 | $174.17 | 57,037.0000 | 213,273,469 | 1.81% | 0.00% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 87290 | $0.00 | 0.0000 | 213,273,469 | 100.00% | 0.04% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Stock Option (right to buy) | 27600 | $0.00 | 27,600.0000 | 213,273,469 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 200 | $177.78 | 41,754.0000 | 213,273,469 | 0.48% | 0.00% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 9125 | $177.17 | 41,954.0000 | 213,273,469 | 17.86% | 0.00% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 12832 | $176.08 | 51,079.0000 | 213,273,469 | 20.08% | 0.01% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 34103 | $175.17 | 63,911.0000 | 213,273,469 | 34.79% | 0.02% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 31030 | $174.28 | 98,014.0000 | 213,273,469 | 24.05% | 0.01% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 87290 | $13.91 | 129,044.0000 | 213,273,469 | 209.06% | 0.04% |
| Jan. 2, 2026 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Common Stock | 5293 | $0.00 | 41,754.0000 | 213,273,469 | 14.52% | 0.00% |
| Jan. 2, 2026 | Smith Michael Alexander | Chief Legal Officer | A | Stock Option (right to buy) | 27600 | $0.00 | 27,600.0000 | 213,273,469 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Smith Michael Alexander | Chief Legal Officer | A | Common Stock | 5293 | $0.00 | 60,195.0000 | 213,273,469 | 9.64% | 0.00% |
| Jan. 2, 2026 | Adsett Roger | Chief Operating Officer | A | Stock Option (right to buy) | 31280 | $0.00 | 31,280.0000 | 213,273,469 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Adsett Roger | Chief Operating Officer | A | Common Stock | 5998 | $0.00 | 111,891.0000 | 213,273,469 | 5.66% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 7945 | $0.00 | 31,780.0000 | 213,273,469 | 20.00% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 4358 | $0.00 | 8,715.0000 | 213,273,469 | 33.34% | 0.00% |
| Jan. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | A | Stock Option (right to buy) | 31280 | $0.00 | 31,280.0000 | 213,273,469 | 9999.99% | 0.01% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 702 | $175.73 | 94,754.0000 | 213,273,469 | 0.74% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 655 | $174.28 | 95,456.0000 | 213,273,469 | 0.68% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1820 | $173.45 | 96,111.0000 | 213,273,469 | 1.86% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 286 | $171.92 | 97,931.0000 | 213,273,469 | 0.29% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 2836 | $171.19 | 98,217.0000 | 213,273,469 | 2.81% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 3205 | $170.61 | 101,053.0000 | 213,273,469 | 3.07% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 2799 | $169.29 | 104,258.0000 | 213,273,469 | 2.61% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 7945 | $29.13 | 107,057.0000 | 213,273,469 | 8.02% | 0.00% |
| Jan. 5, 2026 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 4358 | $19.74 | 99,112.0000 | 213,273,469 | 4.60% | 0.00% |
| Jan. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 5645 | $0.00 | 94,754.0000 | 213,273,469 | 6.33% | 0.00% |
| Jan. 2, 2026 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 5998 | $0.00 | 89,109.0000 | 213,273,469 | 7.22% | 0.00% |
| Jan. 2, 2026 | Lewis William | Chair and CEO | A | Stock Option (right to buy) | 110400 | $0.00 | 110,400.0000 | 213,273,469 | 9999.99% | 0.05% |
| Jan. 2, 2026 | Lewis William | Chair and CEO | A | Common Stock | 21172 | $0.00 | 609,507.0000 | 213,273,469 | 3.60% | 0.01% |
| Jan. 2, 2026 | Bonstein Sara | Chief Financial Officer | A | Stock Option (right to buy) | 31280 | $0.00 | 31,280.0000 | 213,273,469 | 9999.99% | 0.01% |
| Jan. 2, 2026 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 5645 | $0.00 | 85,148.0000 | 213,273,469 | 7.10% | 0.00% |
| Jan. 2, 2026 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 5998 | $0.00 | 79,503.0000 | 213,273,469 | 8.16% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 87,627.0000 | 213,273,469 | 6.67% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 62,160.0000 | 213,273,469 | 6.67% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 51 | $171.20 | 588,335.0000 | 213,273,469 | 0.01% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 362 | $170.26 | 588,386.0000 | 213,273,469 | 0.06% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1938 | $169.58 | 588,748.0000 | 213,273,469 | 0.33% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2175 | $168.54 | 590,686.0000 | 213,273,469 | 0.37% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1431 | $167.29 | 592,861.0000 | 213,273,469 | 0.24% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1783 | $166.60 | 594,292.0000 | 213,273,469 | 0.30% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 697 | $165.21 | 596,075.0000 | 213,273,469 | 0.12% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 447 | $164.24 | 596,772.0000 | 213,273,469 | 0.07% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1465 | $163.19 | 597,219.0000 | 213,273,469 | 0.24% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 350 | $162.26 | 598,684.0000 | 213,273,469 | 0.06% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 599,034.0000 | 213,273,469 | 1.06% | 0.00% |
| Dec. 18, 2025 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 592,775.0000 | 213,273,469 | 0.75% | 0.00% |
| Dec. 5, 2025 | SHAROKY MELVIN MD | Director | S | Common Stock | 20000 | $205.01 | 269,796.0000 | 213,273,469 | 6.90% | 0.01% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 4440 | $0.00 | 66,600.0000 | 213,273,469 | 6.25% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6259 | $0.00 | 93,886.0000 | 213,273,469 | 6.25% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1040 | $207.42 | 588,335.0000 | 213,273,469 | 0.18% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2921 | $206.49 | 589,375.0000 | 213,273,469 | 0.49% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2222 | $205.66 | 592,296.0000 | 213,273,469 | 0.37% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4516 | $204.62 | 594,518.0000 | 213,273,469 | 0.75% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | M | Common Stock | 4440 | $17.16 | 599,034.0000 | 213,273,469 | 0.75% | 0.00% |
| Dec. 4, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6259 | $30.46 | 594,594.0000 | 213,273,469 | 1.06% | 0.00% |
| Dec. 1, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 8895 | $0.00 | 44,475.0000 | 213,273,469 | 16.67% | 0.00% |
| Dec. 1, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1559 | $207.73 | 83,111.0000 | 213,273,469 | 1.84% | 0.00% |
| Dec. 1, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 5886 | $207.03 | 84,670.0000 | 213,273,469 | 6.50% | 0.00% |
| Dec. 1, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1450 | $205.98 | 90,556.0000 | 213,273,469 | 1.58% | 0.00% |
| Dec. 1, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 8895 | $25.83 | 92,006.0000 | 213,273,469 | 10.70% | 0.00% |
| Nov. 24, 2025 | ANDERSON ELIZABETH M | Director | S | Common Stock | 5000 | $204.58 | 58,729.0000 | 213,273,469 | 7.85% | 0.00% |
| Nov. 17, 2025 | LEE LEO | Director | S | Common Stock | 15174 | $197.40 | 54,677.0000 | 213,273,469 | 21.72% | 0.01% |
| Nov. 17, 2025 | LEE LEO | Director | S | Common Stock | 24076 | $196.61 | 69,851.0000 | 213,273,469 | 25.63% | 0.01% |
| Nov. 17, 2025 | LEE LEO | Director | S | Common Stock | 14944 | $195.39 | 93,927.0000 | 213,273,469 | 13.73% | 0.01% |
| Nov. 17, 2025 | LEE LEO | Director | S | Common Stock | 17594 | $194.49 | 108,871.0000 | 213,273,469 | 13.91% | 0.01% |
| Nov. 17, 2025 | LEE LEO | Director | S | Common Stock | 3212 | $193.51 | 126,465.0000 | 213,273,469 | 2.48% | 0.00% |
| Nov. 14, 2025 | ANDERSON ELIZABETH M | Director | S | Common Stock | 10000 | $195.87 | 63,729.0000 | 213,273,469 | 13.56% | 0.00% |
| Nov. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 30000 | $0.00 | 15,760.0000 | 213,273,469 | 65.56% | 0.01% |
| Nov. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 164 | $195.88 | 36,461.0000 | 213,273,469 | 0.45% | 0.00% |
| Nov. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 19183 | $194.44 | 36,625.0000 | 213,273,469 | 34.37% | 0.01% |
| Nov. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 6575 | $193.64 | 55,808.0000 | 213,273,469 | 10.54% | 0.00% |
| Nov. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 4078 | $192.45 | 62,383.0000 | 213,273,469 | 6.14% | 0.00% |
| Nov. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 30000 | $26.46 | 66,461.0000 | 213,273,469 | 82.28% | 0.01% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 12224 | $189.36 | 96,646.0000 | 213,273,469 | 11.23% | 0.01% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 18277 | $0.00 | 54,833.0000 | 213,273,469 | 25.00% | 0.01% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 12949 | $0.00 | 12,949.0000 | 213,273,469 | 50.00% | 0.01% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 2913 | $191.04 | 83,111.0000 | 213,273,469 | 3.39% | 0.00% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 10622 | $190.33 | 86,024.0000 | 213,273,469 | 10.99% | 0.00% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 5467 | $188.38 | 108,870.0000 | 213,273,469 | 4.78% | 0.00% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 18277 | $18.95 | 114,337.0000 | 213,273,469 | 19.03% | 0.01% |
| Nov. 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 12949 | $17.07 | 96,060.0000 | 213,273,469 | 15.58% | 0.01% |
| Nov. 6, 2025 | Brennan David R | Director | G | Common Stock | 60000 | $0.00 | 126,933.0000 | 213,273,469 | 32.10% | 0.03% |
| Nov. 6, 2025 | Brennan David R | Director | G | Common Stock | 60000 | $0.00 | 126,933.0000 | 213,273,469 | 89.64% | 0.03% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1572 | $187.15 | 56,302.0000 | 213,273,469 | 2.72% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 3636 | $185.93 | 57,874.0000 | 213,273,469 | 5.91% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 7619 | $181.88 | 73,071.0000 | 213,273,469 | 9.44% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 4032 | $183.92 | 64,753.0000 | 213,273,469 | 5.86% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1342 | $181.01 | 80,690.0000 | 213,273,469 | 1.64% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 4286 | $182.60 | 68,785.0000 | 213,273,469 | 5.87% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1400 | $187.97 | 54,902.0000 | 213,273,469 | 2.49% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 3243 | $184.91 | 61,510.0000 | 213,273,469 | 5.01% | 0.00% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 27130 | $23.75 | 82,032.0000 | 213,273,469 | 49.42% | 0.01% |
| Nov. 3, 2025 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 27130 | $0.00 | 0.0000 | 213,273,469 | 100.00% | 0.01% |
| Sept. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 6158 | $147.46 | 36,461.0000 | 180,999,350 | 14.45% | 0.00% |
| Sept. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 56520 | $23.75 | 112,981.0000 | 180,999,350 | 100.10% | 0.03% |
| Sept. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 32091 | $144.60 | 80,890.0000 | 180,999,350 | 28.40% | 0.02% |
| Sept. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 30967 | $145.67 | 49,923.0000 | 180,999,350 | 38.28% | 0.02% |
| Sept. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 7304 | $146.57 | 42,619.0000 | 180,999,350 | 14.63% | 0.00% |
| Sept. 12, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 56520 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.03% |
| Sept. 11, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 2000 | $0.00 | 304,505.0000 | 180,999,350 | 0.65% | 0.00% |
| Sept. 11, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 159 | $0.00 | 294,664.0000 | 180,999,350 | 0.05% | 0.00% |
| Sept. 11, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 159 | $0.00 | 304,664.0000 | 180,999,350 | 0.05% | 0.00% |
| Sept. 12, 2025 | SHAROKY MELVIN MD | Director | S | Common Stock | 10000 | $145.39 | 294,664.0000 | 180,999,350 | 3.28% | 0.01% |
| Sept. 4, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | G | Common Stock | 23303 | $0.00 | 56,461.0000 | 180,999,350 | 29.21% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 23835 | $0.00 | 39,725.0000 | 180,999,350 | 37.50% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 17160 | $26.46 | 113,951.0000 | 180,999,350 | 17.73% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 25710 | $26.43 | 139,661.0000 | 180,999,350 | 22.56% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 38846 | $17.07 | 178,507.0000 | 180,999,350 | 27.81% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 13072 | $19.74 | 191,579.0000 | 180,999,350 | 7.32% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 36555 | $18.95 | 228,134.0000 | 180,999,350 | 19.08% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 23835 | $29.13 | 251,969.0000 | 180,999,350 | 10.45% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 17790 | $25.83 | 269,759.0000 | 180,999,350 | 7.06% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 19066 | $141.27 | 250,693.0000 | 180,999,350 | 7.07% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 5877 | $142.03 | 244,816.0000 | 180,999,350 | 2.34% | 0.00% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 35245 | $143.16 | 209,571.0000 | 180,999,350 | 14.40% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 28063 | $144.05 | 181,508.0000 | 180,999,350 | 13.39% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 63782 | $145.33 | 117,726.0000 | 180,999,350 | 35.14% | 0.04% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 34615 | $146.05 | 83,111.0000 | 180,999,350 | 29.40% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 13680 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 17160 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 25710 | $0.00 | 8,570.0000 | 180,999,350 | 75.00% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 38846 | $0.00 | 25,898.0000 | 180,999,350 | 60.00% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 13072 | $0.00 | 13,073.0000 | 180,999,350 | 50.00% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 36555 | $0.00 | 73,110.0000 | 180,999,350 | 33.33% | 0.02% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 17790 | $0.00 | 53,370.0000 | 180,999,350 | 25.00% | 0.01% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1100 | $142.06 | 76,720.0000 | 180,999,350 | 1.41% | 0.00% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 7391 | $143.16 | 69,329.0000 | 180,999,350 | 9.63% | 0.00% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 8300 | $144.16 | 61,029.0000 | 180,999,350 | 11.97% | 0.00% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1354 | $141.16 | 77,820.0000 | 180,999,350 | 1.71% | 0.00% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 4944 | $145.18 | 56,085.0000 | 180,999,350 | 8.10% | 0.00% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1183 | $145.89 | 54,902.0000 | 180,999,350 | 2.11% | 0.00% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 12780 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.01% |
| Sept. 2, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 13680 | $34.03 | 96,791.0000 | 180,999,350 | 16.46% | 0.01% |
| Sept. 2, 2025 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 12780 | $30.46 | 79,174.0000 | 180,999,350 | 19.25% | 0.01% |
| Aug. 19, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 4807 | $128.27 | 105,637.0000 | 180,999,350 | 4.35% | 0.00% |
| Aug. 19, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 20193 | $127.42 | 110,444.0000 | 180,999,350 | 15.46% | 0.01% |
| Aug. 20, 2025 | SHAROKY MELVIN MD | Director | S | Common Stock | 10000 | $129.50 | 306,664.0000 | 180,999,350 | 3.16% | 0.01% |
| Aug. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2481 | $128.76 | 589,751.0000 | 180,999,350 | 0.42% | 0.00% |
| Aug. 18, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6865 | $10.85 | 595,200.0000 | 180,999,350 | 1.17% | 0.00% |
| Aug. 18, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6865 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.00% |
| Aug. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1416 | $129.47 | 588,335.0000 | 180,999,350 | 0.24% | 0.00% |
| Aug. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2968 | $127.59 | 592,232.0000 | 180,999,350 | 0.50% | 0.00% |
| Aug. 14, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 3554 | $126.57 | 86,210.0000 | 180,999,350 | 3.96% | 0.00% |
| Aug. 14, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 700 | $128.16 | 79,764.0000 | 180,999,350 | 0.87% | 0.00% |
| Aug. 14, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 5746 | $127.71 | 80,464.0000 | 180,999,350 | 6.67% | 0.00% |
| Aug. 12, 2025 | SHAROKY MELVIN MD | Director | S | Common Stock | 10000 | $121.58 | 340,478.0000 | 180,999,350 | 2.85% | 0.01% |
| Aug. 13, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 6100 | $0.00 | 334,378.0000 | 180,999,350 | 1.79% | 0.00% |
| Aug. 13, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 15000 | $0.00 | 334,378.0000 | 180,999,350 | 4.29% | 0.01% |
| Aug. 13, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 5000 | $0.00 | 334,378.0000 | 180,999,350 | 1.52% | 0.00% |
| Aug. 4, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 595,165.0000 | 180,999,350 | 1.16% | 0.00% |
| Aug. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1693 | $108.80 | 593,472.0000 | 180,999,350 | 0.28% | 0.00% |
| Aug. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3199 | $109.68 | 590,273.0000 | 180,999,350 | 0.54% | 0.00% |
| Aug. 4, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1938 | $110.91 | 588,335.0000 | 180,999,350 | 0.33% | 0.00% |
| Aug. 4, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 6,865.0000 | 180,999,350 | 49.87% | 0.00% |
| Aug. 4, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 8715 | $19.74 | 91,826.0000 | 180,999,350 | 10.49% | 0.00% |
| Aug. 4, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 8715 | $109.50 | 83,111.0000 | 180,999,350 | 9.49% | 0.00% |
| Aug. 4, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 8715 | $0.00 | 26,145.0000 | 180,999,350 | 25.00% | 0.00% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3443 | $26.46 | 87,460.0000 | 180,999,350 | 4.10% | 0.00% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 11455 | $28.88 | 98,915.0000 | 180,999,350 | 13.10% | 0.01% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 15890 | $29.13 | 114,805.0000 | 180,999,350 | 16.06% | 0.01% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 17100 | $34.03 | 131,905.0000 | 180,999,350 | 14.89% | 0.01% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 32090 | $102.38 | 99,815.0000 | 180,999,350 | 24.33% | 0.02% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 26310 | $103.03 | 73,505.0000 | 180,999,350 | 26.36% | 0.01% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3443 | $0.00 | 8,580.0000 | 180,999,350 | 28.64% | 0.00% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 11455 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.01% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 15890 | $0.00 | 47,670.0000 | 180,999,350 | 25.00% | 0.01% |
| July 21, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 17100 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.01% |
| July 15, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 13,695.0000 | 180,999,350 | 33.28% | 0.00% |
| July 11, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 748 | $96.41 | 67,327.0000 | 180,999,350 | 1.10% | 0.00% |
| July 15, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 933 | $102.51 | 66,394.0000 | 180,999,350 | 1.39% | 0.00% |
| July 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2168 | $101.71 | 592,997.0000 | 180,999,350 | 0.36% | 0.00% |
| July 15, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 595,165.0000 | 180,999,350 | 1.16% | 0.00% |
| July 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4492 | $102.66 | 588,505.0000 | 180,999,350 | 0.76% | 0.00% |
| July 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 170 | $103.32 | 588,335.0000 | 180,999,350 | 0.03% | 0.00% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 6244 | $0.00 | 18,880.0000 | 180,999,350 | 24.85% | 0.00% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 23565 | $0.00 | 15,710.0000 | 180,999,350 | 60.00% | 0.01% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 13717 | $0.00 | 12,023.0000 | 180,999,350 | 53.29% | 0.01% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 4362 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.00% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 6244 | $19.74 | 100,137.0000 | 180,999,350 | 6.65% | 0.00% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 4362 | $24.70 | 104,499.0000 | 180,999,350 | 4.36% | 0.00% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 23565 | $26.43 | 128,064.0000 | 180,999,350 | 22.55% | 0.01% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 13717 | $26.46 | 141,781.0000 | 180,999,350 | 10.71% | 0.01% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 35583 | $95.66 | 106,198.0000 | 180,999,350 | 25.10% | 0.02% |
| July 7, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 22181 | $96.19 | 84,017.0000 | 180,999,350 | 20.89% | 0.01% |
| July 1, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 595,165.0000 | 180,999,350 | 1.16% | 0.00% |
| July 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3666 | $97.73 | 591,499.0000 | 180,999,350 | 0.62% | 0.00% |
| July 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 815 | $99.61 | 588,335.0000 | 180,999,350 | 0.14% | 0.00% |
| July 1, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 20,525.0000 | 180,999,350 | 24.97% | 0.00% |
| July 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2349 | $98.83 | 589,150.0000 | 180,999,350 | 0.40% | 0.00% |
| June 23, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 12636 | $0.00 | 25,124.0000 | 180,999,350 | 33.46% | 0.01% |
| June 23, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 49104 | $101.71 | 102,197.0000 | 180,999,350 | 32.45% | 0.03% |
| June 23, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 12636 | $19.74 | 151,301.0000 | 180,999,350 | 9.11% | 0.01% |
| June 23, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 35253 | $18.95 | 138,665.0000 | 180,999,350 | 34.09% | 0.02% |
| June 23, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 8661 | $102.15 | 93,536.0000 | 180,999,350 | 8.47% | 0.00% |
| June 23, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 35253 | $0.00 | 99,007.0000 | 180,999,350 | 26.26% | 0.02% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 7000 | $98.50 | 710,783.0000 | 180,999,350 | 0.98% | 0.00% |
| June 16, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 4186 | $99.32 | 130,637.0000 | 180,999,350 | 3.10% | 0.00% |
| June 16, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 6500 | $98.50 | 134,823.0000 | 180,999,350 | 4.60% | 0.00% |
| June 16, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 129805 | $0.00 | 27,355.0000 | 180,999,350 | 82.59% | 0.07% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 41784 | $101.23 | 587,978.0000 | 180,999,350 | 6.63% | 0.02% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 48531 | $100.54 | 629,762.0000 | 180,999,350 | 7.15% | 0.03% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 32490 | $99.51 | 678,293.0000 | 180,999,350 | 4.57% | 0.02% |
| June 16, 2025 | Lewis William | Chair and CEO | M | Common Stock | 129805 | $10.85 | 717,783.0000 | 180,999,350 | 22.08% | 0.07% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 904 | $101.39 | 587,978.0000 | 180,999,350 | 0.15% | 0.00% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2300 | $100.70 | 588,882.0000 | 180,999,350 | 0.39% | 0.00% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1558 | $99.65 | 591,182.0000 | 180,999,350 | 0.26% | 0.00% |
| June 16, 2025 | Lewis William | Chair and CEO | S | Common Stock | 442 | $98.51 | 592,740.0000 | 180,999,350 | 0.07% | 0.00% |
| June 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 25740 | $26.46 | 108,851.0000 | 180,999,350 | 30.97% | 0.01% |
| June 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 25740 | $88.64 | 83,111.0000 | 180,999,350 | 23.65% | 0.01% |
| June 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 19423 | $17.07 | 102,534.0000 | 180,999,350 | 23.37% | 0.01% |
| June 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 19423 | $94.50 | 83,111.0000 | 180,999,350 | 18.94% | 0.01% |
| June 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 25740 | $0.00 | 17,160.0000 | 180,999,350 | 60.00% | 0.01% |
| June 11, 2025 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 19423 | $0.00 | 64,744.0000 | 180,999,350 | 23.08% | 0.01% |
| June 10, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 38300 | $17.16 | 156,879.0000 | 180,999,350 | 32.30% | 0.02% |
| June 10, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 38300 | $88.64 | 118,579.0000 | 180,999,350 | 24.41% | 0.02% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 70000 | $13.91 | 188,579.0000 | 180,999,350 | 59.03% | 0.04% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 35072 | $91.68 | 153,507.0000 | 180,999,350 | 18.60% | 0.02% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 18319 | $92.73 | 135,188.0000 | 180,999,350 | 11.93% | 0.01% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 10781 | $93.48 | 124,407.0000 | 180,999,350 | 7.97% | 0.01% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 34500 | $95.49 | 89,907.0000 | 180,999,350 | 27.73% | 0.02% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 500 | $96.02 | 89,407.0000 | 180,999,350 | 0.56% | 0.00% |
| June 10, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 38300 | $0.00 | 0.0000 | 180,999,350 | 100.00% | 0.02% |
| June 11, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 70000 | $0.00 | 87,290.0000 | 180,999,350 | 44.50% | 0.04% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 24150 | $18.95 | 137,438.0000 | 180,999,350 | 21.32% | 0.01% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 23740 | $17.07 | 161,178.0000 | 180,999,350 | 17.27% | 0.01% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 7277 | $87.12 | 153,901.0000 | 180,999,350 | 4.51% | 0.00% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 7310 | $88.29 | 146,591.0000 | 180,999,350 | 4.75% | 0.00% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 20926 | $88.99 | 125,665.0000 | 180,999,350 | 14.28% | 0.01% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 15825 | $89.85 | 109,840.0000 | 180,999,350 | 12.59% | 0.01% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 6328 | $90.93 | 103,512.0000 | 180,999,350 | 5.76% | 0.00% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 100 | $91.66 | 103,412.0000 | 180,999,350 | 0.10% | 0.00% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 24150 | $0.00 | 134,260.0000 | 180,999,350 | 15.25% | 0.01% |
| June 10, 2025 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 23740 | $0.00 | 35,610.0000 | 180,999,350 | 40.00% | 0.01% |
| June 5, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1879 | $73.50 | 67,718.0000 | 180,999,350 | 2.70% | 0.00% |
| June 3, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1448 | $71.50 | 69,597.0000 | 180,999,350 | 2.04% | 0.00% |
| June 3, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1686 | $71.50 | 83,111.0000 | 180,999,350 | 1.99% | 0.00% |
| June 3, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 1860 | $71.50 | 141,323.0000 | 180,999,350 | 1.30% | 0.00% |
| June 3, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1579 | $71.50 | 113,288.0000 | 180,999,350 | 1.37% | 0.00% |
| June 3, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 1642 | $71.50 | 118,579.0000 | 180,999,350 | 1.37% | 0.00% |
| June 3, 2025 | MCGIRR DAVID W J | Director | S | Common Stock | 3250 | $71.30 | 100,723.0000 | 180,999,350 | 3.13% | 0.00% |
| June 4, 2025 | MCGIRR DAVID W J | Director | S | Common Stock | 3000 | $73.27 | 97,723.0000 | 180,999,350 | 2.98% | 0.00% |
| June 2, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 600,012.0000 | 180,999,350 | 1.15% | 0.00% |
| June 2, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1000 | $70.23 | 599,012.0000 | 180,999,350 | 0.17% | 0.00% |
| June 2, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4400 | $71.35 | 594,612.0000 | 180,999,350 | 0.73% | 0.00% |
| June 2, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1430 | $71.94 | 593,182.0000 | 180,999,350 | 0.24% | 0.00% |
| June 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 5472 | $71.50 | 593,182.0000 | 180,999,350 | 0.91% | 0.00% |
| June 2, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 157,160.0000 | 180,999,350 | 4.16% | 0.00% |
| May 30, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 6327 | $68.56 | 91,045.0000 | 180,999,350 | 6.50% | 0.00% |
| May 30, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 20000 | $70.00 | 71,045.0000 | 180,999,350 | 21.97% | 0.01% |
| May 27, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 200 | $0.00 | 360,478.0000 | 180,999,350 | 0.06% | 0.00% |
| May 20, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 400 | $0.00 | 360,678.0000 | 180,999,350 | 0.11% | 0.00% |
| May 20, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 100 | $0.00 | 360,678.0000 | 180,999,350 | 0.03% | 0.00% |
| May 20, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 100 | $0.00 | 360,678.0000 | 180,999,350 | 0.03% | 0.00% |
| May 20, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 100 | $0.00 | 360,678.0000 | 180,999,350 | 0.03% | 0.00% |
| May 20, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 100 | $0.00 | 360,678.0000 | 180,999,350 | 0.03% | 0.00% |
| May 20, 2025 | Desjardins Clarissa | Director | P | Common Stock | 1895 | $66.87 | 68,902.0000 | 180,999,350 | 2.83% | 0.00% |
| May 21, 2025 | Desjardins Clarissa | Director | P | Common Stock | 1130 | $66.35 | 70,032.0000 | 180,999,350 | 1.64% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | S | Common Stock | 9489 | $66.87 | 610,222.0000 | 180,999,350 | 1.53% | 0.01% |
| May 20, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4480 | $67.96 | 605,742.0000 | 180,999,350 | 0.73% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | S | Common Stock | 7088 | $68.49 | 598,654.0000 | 180,999,350 | 1.17% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 605,484.0000 | 180,999,350 | 1.14% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2863 | $66.90 | 602,621.0000 | 180,999,350 | 0.47% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2251 | $68.13 | 600,370.0000 | 180,999,350 | 0.37% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1716 | $68.54 | 598,654.0000 | 180,999,350 | 0.29% | 0.00% |
| May 20, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 163,990.0000 | 180,999,350 | 4.00% | 0.00% |
| May 15, 2025 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 6508 | $0.00 | 114,867.0000 | 180,999,350 | 6.01% | 0.00% |
| May 15, 2025 | Bonstein Sara | Chief Financial Officer | A | Stock Option (right to buy) | 31610 | $0.00 | 31,610.0000 | 180,999,350 | 9999.99% | 0.02% |
| May 15, 2025 | Adsett Roger | Chief Operating Officer | A | Common Stock | 6508 | $0.00 | 143,183.0000 | 180,999,350 | 4.76% | 0.00% |
| May 15, 2025 | Adsett Roger | Chief Operating Officer | A | Stock Option (right to buy) | 31610 | $0.00 | 31,610.0000 | 180,999,350 | 9999.99% | 0.02% |
| May 15, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Common Stock | 5578 | $0.00 | 120,221.0000 | 180,999,350 | 4.87% | 0.00% |
| May 15, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Stock Option (right to buy) | 27100 | $0.00 | 27,100.0000 | 180,999,350 | 9999.99% | 0.01% |
| May 15, 2025 | Lewis William | Chair and CEO | A | Common Stock | 22314 | $0.00 | 619,711.0000 | 180,999,350 | 3.74% | 0.01% |
| May 15, 2025 | Lewis William | Chair and CEO | A | Stock Option (right to buy) | 108380 | $0.00 | 108,380.0000 | 180,999,350 | 9999.99% | 0.06% |
| May 15, 2025 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 6508 | $0.00 | 96,521.0000 | 180,999,350 | 7.23% | 0.00% |
| May 15, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 9925 | $65.47 | 86,596.0000 | 180,999,350 | 10.28% | 0.01% |
| May 16, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1799 | $67.53 | 84,797.0000 | 180,999,350 | 2.08% | 0.00% |
| May 15, 2025 | Flammer Martina M.D. | Chief Medical Officer | A | Stock Option (right to buy) | 31610 | $0.00 | 31,610.0000 | 180,999,350 | 9999.99% | 0.02% |
| May 15, 2025 | Smith Michael Alexander | Chief Legal Officer | A | Common Stock | 5578 | $0.00 | 97,372.0000 | 180,999,350 | 6.08% | 0.00% |
| May 15, 2025 | Smith Michael Alexander | Chief Legal Officer | A | Stock Option (right to buy) | 27100 | $0.00 | 27,100.0000 | 180,999,350 | 9999.99% | 0.01% |
| May 15, 2025 | Brennan David R | Director | A | Common Stock | 5058 | $0.00 | 126,933.0000 | 180,999,350 | 4.15% | 0.00% |
| May 15, 2025 | SCHAFER CAROL | Director | A | Common Stock | 5058 | $0.00 | 63,317.0000 | 180,999,350 | 8.68% | 0.00% |
| May 15, 2025 | Desjardins Clarissa | Director | A | Common Stock | 5058 | $0.00 | 67,007.0000 | 180,999,350 | 8.16% | 0.00% |
| May 15, 2025 | SHAROKY MELVIN MD | Director | A | Common Stock | 5058 | $0.00 | 360,678.0000 | 180,999,350 | 1.42% | 0.00% |
| May 15, 2025 | ANDERSON ELIZABETH M | Director | A | Common Stock | 5058 | $0.00 | 73,729.0000 | 180,999,350 | 7.37% | 0.00% |
| May 15, 2025 | MCGIRR DAVID W J | Director | A | Common Stock | 5058 | $0.00 | 103,973.0000 | 180,999,350 | 5.11% | 0.00% |
| May 15, 2025 | LEE LEO | Director | A | Common Stock | 5058 | $0.00 | 129,677.0000 | 180,999,350 | 4.06% | 0.00% |
| May 13, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 4407 | $67.81 | 92,203.0000 | 180,999,350 | 4.56% | 0.00% |
| May 14, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 409 | $65.61 | 91,794.0000 | 180,999,350 | 0.44% | 0.00% |
| May 13, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 4999 | $67.81 | 115,879.0000 | 180,999,350 | 4.14% | 0.00% |
| May 14, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 1236 | $65.61 | 114,643.0000 | 180,999,350 | 1.07% | 0.00% |
| May 13, 2025 | Lewis William | Chair and CEO | S | Common Stock | 9743 | $66.40 | 608,867.0000 | 180,999,350 | 1.57% | 0.01% |
| May 13, 2025 | Lewis William | Chair and CEO | S | Common Stock | 7699 | $67.70 | 601,168.0000 | 180,999,350 | 1.26% | 0.00% |
| May 14, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3771 | $65.61 | 597,397.0000 | 180,999,350 | 0.63% | 0.00% |
| May 13, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 8408 | $67.81 | 91,757.0000 | 180,999,350 | 8.39% | 0.00% |
| May 14, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1744 | $65.61 | 90,013.0000 | 180,999,350 | 1.90% | 0.00% |
| May 13, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 8870 | $67.81 | 109,993.0000 | 180,999,350 | 7.46% | 0.00% |
| May 14, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1634 | $65.61 | 108,359.0000 | 180,999,350 | 1.49% | 0.00% |
| May 13, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 7482 | $67.81 | 138,600.0000 | 180,999,350 | 5.12% | 0.00% |
| May 14, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 1925 | $65.61 | 136,675.0000 | 180,999,350 | 1.39% | 0.00% |
| May 14, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 576 | $0.00 | 355,620.0000 | 180,999,350 | 0.16% | 0.00% |
| May 14, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 576 | $0.00 | 355,620.0000 | 180,999,350 | 0.16% | 0.00% |
| May 1, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 625,440.0000 | 180,999,350 | 1.10% | 0.00% |
| May 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2629 | $72.24 | 622,811.0000 | 180,999,350 | 0.42% | 0.00% |
| May 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4201 | $72.78 | 618,610.0000 | 180,999,350 | 0.67% | 0.00% |
| May 1, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 170,820.0000 | 180,999,350 | 3.84% | 0.00% |
| April 15, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 625,440.0000 | 180,999,350 | 1.10% | 0.00% |
| April 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3334 | $69.62 | 622,106.0000 | 180,999,350 | 0.53% | 0.00% |
| April 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2896 | $70.54 | 619,210.0000 | 180,999,350 | 0.47% | 0.00% |
| April 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 600 | $71.30 | 618,610.0000 | 180,999,350 | 0.10% | 0.00% |
| April 15, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 177,650.0000 | 180,999,350 | 3.70% | 0.00% |
| April 1, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 625,440.0000 | 180,999,350 | 1.10% | 0.00% |
| April 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3021 | $72.29 | 622,419.0000 | 180,999,350 | 0.48% | 0.00% |
| April 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 772 | $73.44 | 621,647.0000 | 180,999,350 | 0.12% | 0.00% |
| April 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2232 | $74.78 | 619,415.0000 | 180,999,350 | 0.36% | 0.00% |
| April 1, 2025 | Lewis William | Chair and CEO | S | Common Stock | 805 | $75.26 | 618,610.0000 | 180,999,350 | 0.13% | 0.00% |
| April 1, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 184,480.0000 | 180,999,350 | 3.57% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 191,310.0000 | 180,999,350 | 3.45% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 637,360.0000 | 180,999,350 | 3.03% | 0.01% |
| March 17, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4727 | $75.91 | 632,633.0000 | 180,999,350 | 0.74% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | S | Common Stock | 5907 | $76.87 | 626,726.0000 | 180,999,350 | 0.93% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | S | Common Stock | 8116 | $77.79 | 618,610.0000 | 180,999,350 | 1.29% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 625,440.0000 | 180,999,350 | 1.10% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2023 | $76.00 | 623,417.0000 | 180,999,350 | 0.32% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2070 | $77.01 | 621,347.0000 | 180,999,350 | 0.33% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2737 | $77.83 | 618,610.0000 | 180,999,350 | 0.44% | 0.00% |
| March 17, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 191,310.0000 | 180,999,350 | 8.93% | 0.01% |
| March 3, 2025 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 637,360.0000 | 180,999,350 | 3.03% | 0.01% |
| March 3, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 216,890.0000 | 180,999,350 | 3.05% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 7763 | $78.61 | 621,522.0000 | 180,999,350 | 1.23% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 758 | $77.75 | 629,285.0000 | 180,999,350 | 0.12% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 7317 | $76.24 | 630,043.0000 | 180,999,350 | 1.15% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 216,890.0000 | 180,999,350 | 7.96% | 0.01% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 46 | $80.90 | 618,610.0000 | 180,999,350 | 0.01% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 377 | $79.73 | 618,656.0000 | 180,999,350 | 0.06% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2250 | $78.97 | 619,033.0000 | 180,999,350 | 0.36% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1486 | $78.20 | 621,283.0000 | 180,999,350 | 0.24% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2671 | $76.23 | 622,769.0000 | 180,999,350 | 0.43% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 625,440.0000 | 180,999,350 | 1.10% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 127 | $80.90 | 618,610.0000 | 180,999,350 | 0.02% | 0.00% |
| March 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2785 | $79.43 | 618,737.0000 | 180,999,350 | 0.45% | 0.00% |
| Feb. 25, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 1443 | $0.00 | 355,620.0000 | 180,999,350 | 0.40% | 0.00% |
| Feb. 25, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 481 | $0.00 | 355,620.0000 | 180,999,350 | 0.14% | 0.00% |
| Feb. 25, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 481 | $0.00 | 355,620.0000 | 180,999,350 | 0.14% | 0.00% |
| Feb. 25, 2025 | SHAROKY MELVIN MD | Director | G | Common Stock | 481 | $0.00 | 355,620.0000 | 180,999,350 | 0.14% | 0.00% |
| Feb. 18, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 17622 | $80.28 | 119,563.0000 | 180,999,350 | 12.85% | 0.01% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 637,360.0000 | 180,999,350 | 3.03% | 0.01% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1253 | $79.95 | 636,107.0000 | 180,999,350 | 0.20% | 0.00% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 16743 | $81.08 | 619,364.0000 | 180,999,350 | 2.63% | 0.01% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 754 | $81.67 | 618,610.0000 | 180,999,350 | 0.12% | 0.00% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 625,440.0000 | 180,999,350 | 1.10% | 0.00% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 456 | $80.00 | 624,984.0000 | 180,999,350 | 0.07% | 0.00% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 6074 | $81.07 | 618,910.0000 | 180,999,350 | 0.97% | 0.00% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | S | Common Stock | 300 | $81.81 | 618,610.0000 | 180,999,350 | 0.05% | 0.00% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 242,470.0000 | 180,999,350 | 7.18% | 0.01% |
| Feb. 18, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 242,470.0000 | 180,999,350 | 2.74% | 0.00% |
| Feb. 18, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 700 | $81.00 | 118,863.0000 | 180,999,350 | 0.59% | 0.00% |
| Feb. 11, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 13302 | $80.00 | 142,204.0000 | 0 | 8.55% | 0.00% |
| Feb. 12, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 5019 | $80.00 | 137,185.0000 | 0 | 3.53% | 0.00% |
| Feb. 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 9729 | $77.02 | 128,264.0000 | 0 | 7.05% | 0.00% |
| Feb. 10, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 11053 | $77.02 | 178,004.0000 | 0 | 5.85% | 0.00% |
| Feb. 10, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 5781 | $78.36 | 172,223.0000 | 0 | 3.25% | 0.00% |
| Feb. 10, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 26141 | $79.33 | 146,082.0000 | 0 | 15.18% | 0.00% |
| Feb. 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 5089 | $78.36 | 123,175.0000 | 0 | 3.97% | 0.00% |
| Feb. 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 23010 | $79.33 | 100,165.0000 | 0 | 18.68% | 0.00% |
| Feb. 6, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 20650 | $80.90 | 96,610.0000 | 0 | 17.61% | 0.00% |
| Feb. 5, 2025 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 70943 | $0.00 | 171,108.0000 | 0 | 70.83% | 0.00% |
| Feb. 6, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 33055 | $80.90 | 138,053.0000 | 0 | 19.32% | 0.00% |
| Feb. 7, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 60 | $79.59 | 137,993.0000 | 0 | 0.04% | 0.00% |
| Feb. 5, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Common Stock | 47295 | $0.00 | 144,378.0000 | 0 | 48.72% | 0.00% |
| Feb. 6, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 23500 | $80.90 | 120,878.0000 | 0 | 16.28% | 0.00% |
| Feb. 5, 2025 | Adsett Roger | Chief Operating Officer | A | Common Stock | 88680 | $0.00 | 234,762.0000 | 0 | 60.71% | 0.00% |
| Feb. 6, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 45605 | $80.90 | 189,157.0000 | 0 | 19.43% | 0.00% |
| Feb. 7, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 100 | $79.57 | 189,057.0000 | 0 | 0.05% | 0.00% |
| Feb. 5, 2025 | Lewis William | Chair and CEO | A | Common Stock | 153710 | $0.00 | 817,668.0000 | 0 | 23.15% | 0.00% |
| Feb. 6, 2025 | Lewis William | Chair and CEO | S | Common Stock | 79350 | $80.90 | 738,318.0000 | 0 | 9.70% | 0.00% |
| Feb. 5, 2025 | Wise John Drayton | Chief Commercial Officer | A | Common Stock | 15373 | $0.00 | 140,935.0000 | 0 | 12.24% | 0.00% |
| Feb. 6, 2025 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 7910 | $80.90 | 133,025.0000 | 0 | 5.61% | 0.00% |
| Feb. 7, 2025 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 10 | $78.91 | 133,015.0000 | 0 | 0.01% | 0.00% |
| Feb. 5, 2025 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 65033 | $0.00 | 183,896.0000 | 0 | 54.71% | 0.00% |
| Feb. 6, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 28390 | $80.90 | 155,506.0000 | 0 | 15.44% | 0.00% |
| Feb. 5, 2025 | Smith Michael Alexander | Chief Legal Officer | A | Common Stock | 47295 | $0.00 | 117,260.0000 | 0 | 67.60% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 268,050.0000 | 0 | 6.54% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 682,708.0000 | 0 | 2.82% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 241 | $75.25 | 682,467.0000 | 0 | 0.04% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1872 | $76.35 | 680,595.0000 | 0 | 0.27% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 9869 | $77.97 | 670,726.0000 | 0 | 1.45% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 6768 | $78.44 | 663,958.0000 | 0 | 1.01% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 670,788.0000 | 0 | 1.03% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 41 | $74.86 | 670,747.0000 | 0 | 0.01% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 745 | $76.43 | 670,002.0000 | 0 | 0.11% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3463 | $77.95 | 666,539.0000 | 0 | 0.52% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2581 | $78.40 | 663,958.0000 | 0 | 0.39% | 0.00% |
| Feb. 3, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 268,050.0000 | 0 | 2.48% | 0.00% |
| Jan. 30, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 91140 | $80.00 | 97,083.0000 | 0 | 48.42% | 0.00% |
| Jan. 30, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 50000 | $16.16 | 147,083.0000 | 0 | 51.50% | 0.00% |
| Jan. 30, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 41140 | $13.67 | 188,223.0000 | 0 | 27.97% | 0.00% |
| Jan. 30, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 41140 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 30, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 1499 | $69.40 | 669,289.0000 | 0 | 0.22% | 0.00% |
| Jan. 14, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1384 | $68.72 | 100,165.0000 | 0 | 1.36% | 0.00% |
| Jan. 14, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 1457 | $68.72 | 146,082.0000 | 0 | 0.99% | 0.00% |
| Jan. 14, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 872 | $68.72 | 97,083.0000 | 0 | 0.89% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 695,763.0000 | 0 | 2.77% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 6636 | $69.39 | 689,127.0000 | 0 | 0.95% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 22696 | $70.32 | 666,431.0000 | 0 | 3.29% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2473 | $71.05 | 663,958.0000 | 0 | 0.37% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 670,788.0000 | 0 | 1.03% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 4700 | $70.31 | 664,589.0000 | 0 | 0.70% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | S | Common Stock | 631 | $71.01 | 663,958.0000 | 0 | 0.09% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 293,630.0000 | 0 | 6.00% | 0.00% |
| Jan. 15, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 293,630.0000 | 0 | 2.27% | 0.00% |
| Jan. 7, 2025 | Wise John Drayton | Chief Commercial Officer | M | Common Stock | 10000 | $16.07 | 132,492.0000 | 0 | 8.16% | 0.00% |
| Jan. 7, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 3344 | $65.91 | 102,766.0000 | 0 | 3.15% | 0.00% |
| Jan. 8, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1702 | $66.16 | 101,064.0000 | 0 | 1.66% | 0.00% |
| Jan. 8, 2025 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 6657 | $0.00 | 107,721.0000 | 0 | 6.59% | 0.00% |
| Jan. 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1371 | $63.73 | 106,350.0000 | 0 | 1.27% | 0.00% |
| Jan. 10, 2025 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 4801 | $63.62 | 101,549.0000 | 0 | 4.51% | 0.00% |
| Jan. 8, 2025 | Flammer Martina M.D. | Chief Medical Officer | A | Stock Option (right to buy) | 31930 | $0.00 | 31,930.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 3470 | $65.70 | 114,736.0000 | 0 | 2.94% | 0.00% |
| Jan. 8, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1464 | $66.05 | 113,272.0000 | 0 | 1.28% | 0.00% |
| Jan. 8, 2025 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 6657 | $0.00 | 119,929.0000 | 0 | 5.88% | 0.00% |
| Jan. 10, 2025 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 1066 | $63.72 | 118,863.0000 | 0 | 0.89% | 0.00% |
| Jan. 8, 2025 | Bonstein Sara | Chief Financial Officer | A | Stock Option (right to buy) | 31930 | $0.00 | 31,930.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 2596 | $65.88 | 97,515.0000 | 0 | 2.59% | 0.00% |
| Jan. 8, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 1209 | $65.84 | 96,306.0000 | 0 | 1.24% | 0.00% |
| Jan. 8, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Common Stock | 5706 | $0.00 | 102,012.0000 | 0 | 5.92% | 0.00% |
| Jan. 10, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 965 | $63.87 | 101,047.0000 | 0 | 0.95% | 0.00% |
| Jan. 10, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 3092 | $63.62 | 97,955.0000 | 0 | 3.06% | 0.00% |
| Jan. 8, 2025 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Stock Option (right to buy) | 27370 | $0.00 | 27,370.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 10000 | $65.98 | 122,492.0000 | 0 | 7.55% | 0.00% |
| Jan. 7, 2025 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 2908 | $65.87 | 119,584.0000 | 0 | 2.37% | 0.00% |
| Jan. 8, 2025 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 392 | $66.21 | 119,192.0000 | 0 | 0.33% | 0.00% |
| Jan. 8, 2025 | Wise John Drayton | Chief Commercial Officer | A | Common Stock | 6657 | $0.00 | 125,849.0000 | 0 | 5.59% | 0.00% |
| Jan. 10, 2025 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 287 | $65.40 | 125,562.0000 | 0 | 0.23% | 0.00% |
| Jan. 7, 2025 | Wise John Drayton | Chief Commercial Officer | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 8, 2025 | Wise John Drayton | Chief Commercial Officer | A | Stock Option (right to buy) | 31930 | $0.00 | 31,930.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Lewis William | Chair and CEO | S | Common Stock | 8218 | $66.02 | 661,166.0000 | 0 | 1.23% | 0.00% |
| Jan. 8, 2025 | Lewis William | Chair and CEO | S | Common Stock | 3999 | $65.96 | 657,167.0000 | 0 | 0.60% | 0.00% |
| Jan. 8, 2025 | Lewis William | Chair and CEO | A | Common Stock | 22824 | $0.00 | 679,991.0000 | 0 | 3.47% | 0.00% |
| Jan. 10, 2025 | Lewis William | Chair and CEO | S | Common Stock | 2978 | $63.36 | 677,013.0000 | 0 | 0.44% | 0.00% |
| Jan. 8, 2025 | Lewis William | Chair and CEO | A | Stock Option (right to buy) | 109490 | $0.00 | 109,490.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 2306 | $65.98 | 65,642.0000 | 0 | 3.39% | 0.00% |
| Jan. 8, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 1064 | $66.21 | 64,578.0000 | 0 | 1.62% | 0.00% |
| Jan. 8, 2025 | Smith Michael Alexander | Chief Legal Officer | A | Common Stock | 5706 | $0.00 | 70,284.0000 | 0 | 8.84% | 0.00% |
| Jan. 10, 2025 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 319 | $63.38 | 69,965.0000 | 0 | 0.45% | 0.00% |
| Jan. 8, 2025 | Smith Michael Alexander | Chief Legal Officer | A | Stock Option (right to buy) | 27370 | $0.00 | 27,370.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 2444 | $65.95 | 147,666.0000 | 0 | 1.63% | 0.00% |
| Jan. 8, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 1882 | $66.10 | 145,784.0000 | 0 | 1.27% | 0.00% |
| Jan. 8, 2025 | Adsett Roger | Chief Operating Officer | A | Common Stock | 6657 | $0.00 | 152,441.0000 | 0 | 4.57% | 0.00% |
| Jan. 10, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 1298 | $63.86 | 151,143.0000 | 0 | 0.85% | 0.00% |
| Jan. 10, 2025 | Adsett Roger | Chief Operating Officer | S | Common Stock | 3604 | $63.62 | 147,539.0000 | 0 | 2.38% | 0.00% |
| Jan. 8, 2025 | Adsett Roger | Chief Operating Officer | A | Stock Option (right to buy) | 31930 | $0.00 | 31,930.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2025 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 676,214.0000 | 0 | 1.02% | 0.00% |
| Jan. 2, 2025 | Lewis William | Chair and CEO | S | Common Stock | 6830 | $69.86 | 669,384.0000 | 0 | 1.01% | 0.00% |
| Jan. 2, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 319,210.0000 | 0 | 5.55% | 0.00% |
| Jan. 2, 2025 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 319,210.0000 | 0 | 2.09% | 0.00% |
| Jan. 2, 2025 | Lewis William | Chair and CEO | S | Common Stock | 18750 | $69.84 | 669,384.0000 | 0 | 2.72% | 0.00% |
| Jan. 2, 2025 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 688,134.0000 | 0 | 2.80% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | S | Common Stock | 5240 | $69.71 | 670,974.0000 | 0 | 0.77% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | S | Common Stock | 1590 | $70.61 | 669,384.0000 | 0 | 0.24% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 344,790.0000 | 0 | 5.16% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 344,790.0000 | 0 | 1.94% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 688,134.0000 | 0 | 2.80% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | S | Common Stock | 13162 | $69.65 | 674,972.0000 | 0 | 1.91% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | S | Common Stock | 5588 | $70.52 | 669,384.0000 | 0 | 0.83% | 0.00% |
| Dec. 19, 2024 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 676,214.0000 | 0 | 1.02% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | S | Common Stock | 181 | $74.22 | 669,384.0000 | 0 | 0.03% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 6830 | $0.00 | 370,370.0000 | 0 | 1.81% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | M | Common Stock | 18750 | $22.76 | 688,134.0000 | 0 | 2.80% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | S | Common Stock | 11504 | $72.58 | 676,630.0000 | 0 | 1.67% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | S | Common Stock | 6847 | $73.56 | 669,783.0000 | 0 | 1.01% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | S | Common Stock | 399 | $74.23 | 669,384.0000 | 0 | 0.06% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | M | Common Stock | 6830 | $10.85 | 676,214.0000 | 0 | 1.02% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | S | Common Stock | 4087 | $72.57 | 672,127.0000 | 0 | 0.60% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | S | Common Stock | 2562 | $73.55 | 669,565.0000 | 0 | 0.38% | 0.00% |
| Dec. 12, 2024 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 18750 | $0.00 | 370,370.0000 | 0 | 4.82% | 0.00% |
| Sept. 13, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 26969 | $0.00 | 27,116.0000 | 0 | 49.86% | 0.00% |
| Sept. 13, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 7000 | $22.76 | 95,727.0000 | 0 | 7.89% | 0.00% |
| Sept. 13, 2024 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 9000 | $74.75 | 67,856.0000 | 0 | 11.71% | 0.00% |
| Sept. 13, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 7000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 12, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 635 | $34.03 | 106,769.0000 | 0 | 0.60% | 0.00% |
| Sept. 12, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 635 | $74.92 | 106,134.0000 | 0 | 0.59% | 0.00% |
| Sept. 13, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 26969 | $34.03 | 133,103.0000 | 0 | 25.41% | 0.00% |
| Sept. 13, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 26969 | $74.90 | 106,134.0000 | 0 | 20.26% | 0.00% |
| Sept. 16, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 13436 | $34.03 | 119,570.0000 | 0 | 12.66% | 0.00% |
| Sept. 16, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 13436 | $74.92 | 106,134.0000 | 0 | 11.24% | 0.00% |
| Sept. 13, 2024 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 18871 | $74.16 | 76,856.0000 | 0 | 19.71% | 0.00% |
| Sept. 12, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 635 | $0.00 | 54,085.0000 | 0 | 1.16% | 0.00% |
| Sept. 16, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 13436 | $0.00 | 13,680.0000 | 0 | 49.55% | 0.00% |
| Sept. 10, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 9582 | $71.88 | 100,100.0000 | 0 | 8.74% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 19423 | $0.00 | 84,167.0000 | 0 | 18.75% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 14130 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 34280 | $0.00 | 34,280.0000 | 0 | 50.00% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 18874 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 25740 | $0.00 | 42,900.0000 | 0 | 37.50% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 36555 | $0.00 | 109,665.0000 | 0 | 25.00% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 9064 | $72.61 | 106,134.0000 | 0 | 7.87% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 63483 | $71.43 | 115,198.0000 | 0 | 35.53% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 76455 | $70.90 | 178,681.0000 | 0 | 29.97% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 19423 | $17.07 | 255,136.0000 | 0 | 8.24% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 14130 | $23.75 | 235,713.0000 | 0 | 6.38% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 34280 | $26.43 | 221,583.0000 | 0 | 18.30% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 18874 | $23.66 | 187,303.0000 | 0 | 11.21% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 25740 | $26.46 | 168,429.0000 | 0 | 18.04% | 0.00% |
| Sept. 6, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 36555 | $18.95 | 142,689.0000 | 0 | 34.44% | 0.00% |
| Sept. 10, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 37575 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 10, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 27993 | $71.37 | 109,682.0000 | 0 | 20.33% | 0.00% |
| Sept. 10, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 37575 | $10.85 | 137,675.0000 | 0 | 37.54% | 0.00% |
| Aug. 29, 2024 | SHAROKY MELVIN MD | Director | G | Common Stock | 10000 | $0.00 | 355,620.0000 | 0 | 2.74% | 0.00% |
| Aug. 29, 2024 | SHAROKY MELVIN MD | Director | G | Common Stock | 10000 | $0.00 | 355,620.0000 | 0 | 2.89% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 34530 | $0.00 | 34,530.0000 | 0 | 50.00% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 41640 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 11900 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 20415 | $73.65 | 88,727.0000 | 0 | 18.70% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 67655 | $72.75 | 109,142.0000 | 0 | 38.27% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 11900 | $17.16 | 100,627.0000 | 0 | 13.41% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 34530 | $17.07 | 176,797.0000 | 0 | 24.27% | 0.00% |
| Aug. 12, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 41640 | $13.91 | 142,267.0000 | 0 | 41.38% | 0.00% |
| Aug. 12, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 9469 | $72.49 | 100,100.0000 | 0 | 8.64% | 0.00% |
| July 8, 2024 | Smith Michael Alexander | Chief Legal Officer | F | Common Stock | 730 | $70.05 | 88,727.0000 | 0 | 0.82% | 0.00% |
| June 10, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 21195 | $0.00 | 14,130.0000 | 0 | 60.00% | 0.00% |
| June 10, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 21195 | $60.00 | 106,134.0000 | 0 | 16.65% | 0.00% |
| June 10, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 21195 | $23.75 | 127,329.0000 | 0 | 19.97% | 0.00% |
| June 3, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 41250 | $22.76 | 163,760.0000 | 0 | 33.67% | 0.00% |
| June 3, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 41250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 3, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 13750 | $16.07 | 122,510.0000 | 0 | 12.64% | 0.00% |
| June 3, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 13750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 3, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 55000 | $55.33 | 108,760.0000 | 0 | 33.59% | 0.00% |
| May 28, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 103806 | $49.62 | 106,134.0000 | 0 | 49.45% | 0.00% |
| May 30, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 21195 | $23.75 | 127,329.0000 | 0 | 19.97% | 0.00% |
| May 30, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 21195 | $55.00 | 106,134.0000 | 0 | 16.65% | 0.00% |
| May 28, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 103806 | $0.00 | 18,874.0000 | 0 | 84.62% | 0.00% |
| May 30, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Stock Option (right to buy) | 21195 | $0.00 | 35,325.0000 | 0 | 37.50% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3454 | $28.88 | 120,935.0000 | 0 | 2.94% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 76731 | $28.88 | 197,666.0000 | 0 | 63.45% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3454 | $24.70 | 201,120.0000 | 0 | 1.75% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 27074 | $24.70 | 228,194.0000 | 0 | 13.46% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3454 | $34.03 | 231,648.0000 | 0 | 1.51% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 25046 | $34.03 | 256,694.0000 | 0 | 10.81% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3454 | $26.46 | 260,148.0000 | 0 | 1.35% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 39446 | $26.46 | 299,594.0000 | 0 | 15.16% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3454 | $26.43 | 303,048.0000 | 0 | 1.15% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3454 | $0.00 | 42,146.0000 | 0 | 7.57% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 3454 | $17.07 | 326,613.0000 | 0 | 1.07% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 32156 | $17.07 | 358,769.0000 | 0 | 9.85% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 20724 | $50.01 | 338,045.0000 | 0 | 5.78% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 220564 | $50.00 | 117,481.0000 | 0 | 65.25% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3454 | $0.00 | 88,186.0000 | 0 | 3.77% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 76731 | $0.00 | 11,455.0000 | 0 | 87.01% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3454 | $0.00 | 31,436.0000 | 0 | 9.90% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 27074 | $0.00 | 4,362.0000 | 0 | 86.12% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 25046 | $0.00 | 17,100.0000 | 0 | 59.43% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3454 | $0.00 | 65,186.0000 | 0 | 5.03% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 39446 | $0.00 | 25,740.0000 | 0 | 60.51% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3454 | $0.00 | 59,386.0000 | 0 | 5.50% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 20111 | $0.00 | 39,275.0000 | 0 | 33.86% | 0.00% |
| May 28, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 3454 | $0.00 | 91,506.0000 | 0 | 3.64% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Stock Option (right to buy) | 32156 | $0.00 | 59,350.0000 | 0 | 35.14% | 0.00% |
| May 29, 2024 | Bonstein Sara | Chief Financial Officer | M | Common Stock | 20111 | $26.43 | 323,159.0000 | 0 | 6.64% | 0.00% |
| May 28, 2024 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 1602 | $48.95 | 121,657.0000 | 0 | 1.30% | 0.00% |
| May 28, 2024 | Wise John Drayton | Chief Commercial Officer | M | Common Stock | 6250 | $12.58 | 127,907.0000 | 0 | 5.14% | 0.00% |
| May 28, 2024 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 6250 | $50.00 | 121,657.0000 | 0 | 4.89% | 0.00% |
| May 28, 2024 | Wise John Drayton | Chief Commercial Officer | M | Stock Option (right to buy) | 6250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 7000 | $16.07 | 101,579.0000 | 0 | 7.40% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 10000 | $16.16 | 111,579.0000 | 0 | 9.84% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 3691 | $10.85 | 115,270.0000 | 0 | 3.31% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 3470 | $11.38 | 118,740.0000 | 0 | 3.01% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Common Stock | 14810 | $13.67 | 133,550.0000 | 0 | 12.47% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 44722 | $49.53 | 88,828.0000 | 0 | 33.49% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 7000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 3691 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 3470 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Smith Michael Alexander | Chief Legal Officer | M | Stock Option (right to buy) | 14810 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 27500 | $12.58 | 136,260.0000 | 0 | 25.29% | 0.00% |
| May 28, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 27500 | $49.53 | 108,760.0000 | 0 | 20.18% | 0.00% |
| May 28, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 27500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Flammer Martina M.D. | Chief Medical Officer | M | Common Stock | 103806 | $23.66 | 209,940.0000 | 0 | 97.81% | 0.00% |
| May 17, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 4642 | $25.09 | 106,134.0000 | 0 | 4.19% | 0.00% |
| May 17, 2024 | Adsett Roger | Chief Operating Officer | S | Common Stock | 5945 | $25.09 | 149,275.0000 | 0 | 3.83% | 0.00% |
| May 13, 2024 | Lewis William | Chair and CEO | A | Common Stock | 42707 | $0.00 | 690,747.0000 | 0 | 6.59% | 0.00% |
| May 13, 2024 | ALTOMARI ALFRED | Director | A | Common Stock | 13162 | $0.00 | 69,495.0000 | 0 | 23.36% | 0.00% |
| May 13, 2024 | ANDERSON ELIZABETH M | Director | A | Common Stock | 13162 | $0.00 | 68,671.0000 | 0 | 23.71% | 0.00% |
| May 13, 2024 | Brennan David R | Director | A | Common Stock | 13162 | $0.00 | 121,875.0000 | 0 | 12.11% | 0.00% |
| May 13, 2024 | Desjardins Clarissa | Director | A | Common Stock | 13162 | $0.00 | 61,949.0000 | 0 | 26.98% | 0.00% |
| May 13, 2024 | LEE LEO | Director | A | Common Stock | 13162 | $0.00 | 124,619.0000 | 0 | 11.81% | 0.00% |
| May 13, 2024 | MCGIRR DAVID W J | Director | A | Common Stock | 13162 | $0.00 | 98,915.0000 | 0 | 15.35% | 0.00% |
| May 13, 2024 | SCHAFER CAROL | Director | A | Common Stock | 13162 | $0.00 | 58,259.0000 | 0 | 29.19% | 0.00% |
| May 13, 2024 | SHAROKY MELVIN MD | Director | A | Common Stock | 13162 | $0.00 | 355,620.0000 | 0 | 3.84% | 0.00% |
| May 13, 2024 | Adsett Roger | Chief Operating Officer | A | Stock Option (right to buy) | 71160 | $0.00 | 71,160.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Adsett Roger | Chief Operating Officer | S | Common Stock | 7857 | $25.50 | 155,220.0000 | 0 | 4.82% | 0.00% |
| May 13, 2024 | Adsett Roger | Chief Operating Officer | A | Common Stock | 14518 | $0.00 | 163,077.0000 | 0 | 9.77% | 0.00% |
| May 13, 2024 | Bonstein Sara | Chief Financial Officer | A | Stock Option (right to buy) | 71160 | $0.00 | 71,160.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 11088 | $25.32 | 117,481.0000 | 0 | 8.62% | 0.00% |
| May 13, 2024 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 14518 | $0.00 | 128,569.0000 | 0 | 12.73% | 0.00% |
| May 13, 2024 | Flammer Martina M.D. | Chief Medical Officer | A | Stock Option (right to buy) | 71160 | $0.00 | 71,160.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 10640 | $25.47 | 110,776.0000 | 0 | 8.76% | 0.00% |
| May 13, 2024 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 14518 | $0.00 | 121,416.0000 | 0 | 13.58% | 0.00% |
| May 13, 2024 | Lewis William | Chair and CEO | A | Stock Option (right to buy) | 209320 | $0.00 | 209,320.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Lewis William | Chair and CEO | S | Common Stock | 22198 | $25.52 | 668,549.0000 | 0 | 3.21% | 0.00% |
| May 13, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Stock Option (right to buy) | 65230 | $0.00 | 65,230.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 6508 | $25.53 | 108,760.0000 | 0 | 5.65% | 0.00% |
| May 13, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Common Stock | 13308 | $0.00 | 115,268.0000 | 0 | 13.05% | 0.00% |
| May 13, 2024 | Smith Michael Alexander | Chief Legal Officer | A | Stock Option (right to buy) | 65230 | $0.00 | 65,230.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Smith Michael Alexander | Chief Legal Officer | S | Common Stock | 5093 | $25.40 | 94,579.0000 | 0 | 5.11% | 0.00% |
| May 13, 2024 | Smith Michael Alexander | Chief Legal Officer | A | Common Stock | 13308 | $0.00 | 99,672.0000 | 0 | 15.41% | 0.00% |
| May 13, 2024 | Wise John Drayton | Chief Commercial Officer | A | Stock Option (right to buy) | 71160 | $0.00 | 71,160.0000 | 0 | 9999.99% | 0.00% |
| May 14, 2024 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 5088 | $25.47 | 123,259.0000 | 0 | 3.96% | 0.00% |
| May 13, 2024 | Wise John Drayton | Chief Commercial Officer | A | Common Stock | 14518 | $0.00 | 128,347.0000 | 0 | 12.75% | 0.00% |
| Feb. 28, 2024 | SHAROKY MELVIN MD | Director | G | Common Stock | 1200 | $0.00 | 342,458.0000 | 0 | 0.35% | 0.00% |
| Feb. 28, 2024 | SHAROKY MELVIN MD | Director | G | Common Stock | 3600 | $0.00 | 342,458.0000 | 0 | 1.04% | 0.00% |
| Feb. 28, 2024 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 28, 2024 | Lewis William | Chair and CEO | M | Common Stock | 50000 | $12.58 | 648,040.0000 | 0 | 8.36% | 0.00% |
| Feb. 28, 2024 | SHAROKY MELVIN MD | Director | G | Common Stock | 1200 | $0.00 | 342,458.0000 | 0 | 0.35% | 0.00% |
| Feb. 28, 2024 | SHAROKY MELVIN MD | Director | G | Common Stock | 1200 | $0.00 | 342,458.0000 | 0 | 0.35% | 0.00% |
| Jan. 12, 2024 | Adsett Roger | Chief Operating Officer | S | Common Stock | 5251 | $28.63 | 148,559.0000 | 0 | 3.41% | 0.00% |
| Jan. 12, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 4667 | $28.63 | 106,898.0000 | 0 | 4.18% | 0.00% |
| Jan. 9, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 503 | $29.56 | 105,149.0000 | 0 | 0.48% | 0.00% |
| Jan. 9, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 503 | $20.49 | 105,652.0000 | 0 | 0.48% | 0.00% |
| Jan. 9, 2024 | Smith Michael Alexander | General Counsel, Senior VP | S | Common Stock | 2373 | $28.76 | 86,364.0000 | 0 | 2.67% | 0.00% |
| Jan. 9, 2024 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 1861 | $28.78 | 113,829.0000 | 0 | 1.61% | 0.00% |
| Jan. 10, 2024 | Adsett Roger | Chief Operating Officer | S | Common Stock | 3536 | $28.90 | 153,810.0000 | 0 | 2.25% | 0.00% |
| Jan. 9, 2024 | Adsett Roger | Chief Operating Officer | S | Common Stock | 3837 | $29.25 | 157,346.0000 | 0 | 2.38% | 0.00% |
| Jan. 9, 2024 | Bonstein Sara | Chief Financial Officer | S | Common Stock | 4497 | $29.18 | 114,051.0000 | 0 | 3.79% | 0.00% |
| Jan. 10, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1245 | $28.90 | 111,565.0000 | 0 | 1.10% | 0.00% |
| Jan. 9, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 4715 | $29.01 | 112,810.0000 | 0 | 4.01% | 0.00% |
| Jan. 9, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 503 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 9, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 3165 | $28.74 | 101,984.0000 | 0 | 3.01% | 0.00% |
| Jan. 8, 2024 | Lewis William | Chair and CEO | S | Common Stock | 24951 | $29.11 | 607,962.0000 | 0 | 3.94% | 0.00% |
| Jan. 8, 2024 | Lewis William | Chair and CEO | M | Common Stock | 24951 | $20.49 | 632,913.0000 | 0 | 4.10% | 0.00% |
| Jan. 8, 2024 | Lewis William | Chair and CEO | M | Stock Option (right to buy) | 45120 | $20.49 | 0.0000 | 0 | 0.00% | 0.00% |
| Jan. 9, 2024 | Lewis William | Chair and CEO | S | Common Stock | 9887 | $28.72 | 598,075.0000 | 0 | 1.63% | 0.00% |
| Jan. 8, 2024 | Lewis William | Chair and CEO | S | Common Stock | 20169 | $29.88 | 607,962.0000 | 0 | 3.21% | 0.00% |
| Jan. 8, 2024 | Lewis William | Chair and CEO | M | Common Stock | 20169 | $20.49 | 628,131.0000 | 0 | 3.32% | 0.00% |
| Jan. 4, 2024 | Lewis William | Chair and CEO | A | Common Stock | 37869 | $0.00 | 614,941.0000 | 0 | 6.56% | 0.00% |
| Jan. 4, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Stock Option (right to buy) | 58260 | $0.00 | 58,260.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 1457 | $29.28 | 105,149.0000 | 0 | 1.37% | 0.00% |
| Jan. 4, 2024 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | A | Common Stock | 11800 | $0.00 | 106,606.0000 | 0 | 12.45% | 0.00% |
| Jan. 4, 2024 | Smith Michael Alexander | General Counsel, Senior VP | A | Stock Option (right to buy) | 58260 | $0.00 | 58,260.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Smith Michael Alexander | General Counsel, Senior VP | S | Common Stock | 627 | $29.31 | 88,737.0000 | 0 | 0.70% | 0.00% |
| Jan. 4, 2024 | Smith Michael Alexander | General Counsel, Senior VP | A | Common Stock | 11800 | $0.00 | 89,364.0000 | 0 | 15.21% | 0.00% |
| Jan. 4, 2024 | Wise John Drayton | Chief Commercial Officer | A | Stock Option (right to buy) | 63560 | $0.00 | 63,560.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Wise John Drayton | Chief Commercial Officer | M | Stock Option (right to buy) | 20071 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 5, 2024 | Wise John Drayton | Chief Commercial Officer | S | Common Stock | 1167 | $29.32 | 115,690.0000 | 0 | 1.00% | 0.00% |
| Jan. 4, 2024 | Wise John Drayton | Chief Commercial Officer | A | Common Stock | 12873 | $0.00 | 116,857.0000 | 0 | 12.38% | 0.00% |
| Jan. 3, 2024 | Wise John Drayton | Chief Commercial Officer | S | Stock Option (right to buy) | 20071 | $29.19 | 103,984.0000 | 0 | 16.18% | 0.00% |
| Jan. 3, 2024 | Wise John Drayton | Chief Commercial Officer | M | Stock Option (right to buy) | 20071 | $19.11 | 124,055.0000 | 0 | 19.30% | 0.00% |
| Jan. 4, 2024 | Bonstein Sara | Chief Financial Officer | A | Stock Option (right to buy) | 63560 | $0.00 | 63,560.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2024 | Adsett Roger | Chief Operating Officer | A | Common Stock | 12873 | $0.00 | 164,225.0000 | 0 | 8.51% | 0.00% |
| Jan. 5, 2024 | Adsett Roger | Chief Operating Officer | S | Common Stock | 3042 | $29.21 | 161,183.0000 | 0 | 1.85% | 0.00% |
| Jan. 4, 2024 | Adsett Roger | Chief Operating Officer | A | Stock Option (right to buy) | 63560 | $0.00 | 63,560.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Flammer Martina M.D. | Chief Medical Officer | S | Common Stock | 1386 | $29.21 | 117,525.0000 | 0 | 1.17% | 0.00% |
| Jan. 4, 2024 | Flammer Martina M.D. | Chief Medical Officer | A | Common Stock | 12873 | $0.00 | 118,911.0000 | 0 | 12.14% | 0.00% |
| Jan. 4, 2024 | Flammer Martina M.D. | Chief Medical Officer | A | Stock Option (right to buy) | 63560 | $0.00 | 63,560.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2024 | Bonstein Sara | Chief Financial Officer | A | Common Stock | 12873 | $0.00 | 118,548.0000 | 0 | 12.18% | 0.00% |
| Jan. 4, 2024 | Lewis William | Chair and CEO | A | Stock Option (right to buy) | 186970 | $0.00 | 186,970.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2024 | Lewis William | Chair and CEO | S | Common Stock | 6979 | $29.26 | 607,962.0000 | 0 | 1.13% | 0.00% |
| Dec. 28, 2023 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Common Stock | 22288 | $20.49 | 116,837.0000 | 0 | 23.57% | 0.00% |
| Dec. 28, 2023 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | S | Common Stock | 22288 | $32.00 | 94,549.0000 | 0 | 19.08% | 0.00% |
| Dec. 28, 2023 | Schaeffer Orlov S Nicole | Chief People Strategy Officer | M | Stock Option (right to buy) | 22288 | $0.00 | 503.0000 | 0 | 97.79% | 0.00% |